Navegar por autor "Fernandez Castroagudin, Javier"

A comparison of dobutamine and levosimendan on hepatic blood flow in patients with a low cardiac output state after cardiac surgery: a randomised controlled study

2013- Fernandez Castroagudin, Javier; Álvarez Escudero, Julián; Rodríguez García, Jaime José; Tomé Martínez de Rituerto, Santiago; TABOADA MUÑIZ, MANUEL; [et al.]

Baseline creatinine and hemodynamic response predicts reversal hepatorenal syndrome type 1 with terlipressin and albumin therapy

2012- Molina Perez, Esther; Fernandez Castroagudin, Javier; Domínguez Muñoz, Juan Enrique; Lariño Noia, José; Álvarez del Castillo, Matilde; [et al.]

Basiliximab en el tratamiento del rechazo celular agudo resistente a los corticoides postrasplante hepático

2012- Alvarez Castro, Ana Maria; Seijo Rios, Susana; Molina Perez, Esther; Fernandez Castroagudin, Javier; Varo Perez, Evaristo [et al.]

Calcineurin inhibitors in liver transplantation: to be or not to be.

2011- Molina Perez, Esther; Fernandez Castroagudin, Javier; Varo Perez, Evaristo

Cholangitis and multiple liver abscesses after percutaneous ethanol injection (PEI) for recurrent hepatocellular carcinoma (HCC)

2013- Molina Perez, Esther; Fernandez Castroagudin, Javier; Domínguez Muñoz, Juan Enrique; Vallejo Senra, Nicolau; Baleato Gonzalez, Sandra; [et al.]

Colangitis esclerosante

2012- Molina Perez, Esther; Fernandez Castroagudin, Javier; Domínguez Muñoz, Juan Enrique

Comienzo de hepatitis aguda grave autoinmune refractaria a tratamiento convencional, rescatada con infliximab

2014- Molina Perez, Esther; Fernandez Castroagudin, Javier; Domínguez Muñoz, Juan Enrique; Vallejo Senra, Nicolau

Decisiones terapéuticas en el tratamiento del carcinoma hepatocelular y patrones de uso de sorafenib. Resultados del estudio internacional observacional GIDEON en España

2015- Fernandez Castroagudin, Javier; Turnes Vázquez, Juan; Salgado Fernández, Mercedes; Martín-Granizo Barrenechea, Ignacio

Differences in the incidence and clinical evolution of early neurotoxicity after liver transplantation based on tacrolimus formulation used in the immunosuppressive induction protocol

2014- Molina Perez, Esther; Fernandez Castroagudin, Javier; Varo Perez, Evaristo; Souto Rodríguez, Raquel; Fernández Pérez, Aquilino; [et al.]

Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation

2012- Fernandez Castroagudin, Javier

Estrategias para evitar la hepatitis B de novo postrasplante hepático (II)

2014- Fernandez Castroagudin, Javier

Everolimus treatment in liver transplantation according to clinical practice: A Spanish multicentre cohort

2014- Fernandez Castroagudin, Javier

Intrahepatic Cholangiocarcinoma (I-CC) or Mixed Hepatocellular-Cholangiocarcinoma (HCC-CC) in Patients Undergoing Liver Transplantation (LT)

2013- Fernandez Castroagudin, Javier; Varo Perez, Evaristo; Vazquez Martul, Eduardo

Intrahepatic Cholangiocarcinoma (I-CC) or Mixed Hepatocellular-Cholangiocarcinoma (HCC-CC) in Patients Undergoing Liver Transplantation (LT). A Spanish Case Control Multicenter Study

2013- Fernandez Castroagudin, Javier; Varo Perez, Evaristo; Otero Ferreiro, Alejandra; Vazquez Millan, Mº Angeles

Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation: a Spanish matched cohort multicenter study

2014- Fernandez Castroagudin, Javier; Varo Perez, Evaristo; Otero Ferreiro, Alejandra

Late recurrence of hepatocellular carcinoma after liver transplantation: Is an active surveillance for recurrence needed?

2012- Molina Perez, Esther; Fernandez Castroagudin, Javier; Varo Perez, Evaristo; Abdulkader Nallib, Ihab; Ferreiro Iglesias, Rocio; [et al.]

Profiles and clinical management of hepatitis C patients in Spain: DisHCovery study

2015- Fernandez Castroagudin, Javier; Molina Perez, Esther

Repositorio digital RUNA

Navegar por autor "Fernandez Castroagudin, Javier"

A comparison of dobutamine and levosimendan on hepatic blood flow in patients with a low cardiac output state after cardiac surgery: a randomised controlled study ﻿

Baseline creatinine and hemodynamic response predicts reversal hepatorenal syndrome type 1 with terlipressin and albumin therapy ﻿

Basiliximab en el tratamiento del rechazo celular agudo resistente a los corticoides postrasplante hepático ﻿

Calcineurin inhibitors in liver transplantation: to be or not to be. ﻿

Cholangitis and multiple liver abscesses after percutaneous ethanol injection (PEI) for recurrent hepatocellular carcinoma (HCC) ﻿

Colangitis esclerosante ﻿

Comienzo de hepatitis aguda grave autoinmune refractaria a tratamiento convencional, rescatada con infliximab ﻿

Decisiones terapéuticas en el tratamiento del carcinoma hepatocelular y patrones de uso de sorafenib. Resultados del estudio internacional observacional GIDEON en España ﻿

Differences in the incidence and clinical evolution of early neurotoxicity after liver transplantation based on tacrolimus formulation used in the immunosuppressive induction protocol ﻿

Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation ﻿

Estrategias para evitar la hepatitis B de novo postrasplante hepático (II) ﻿

Everolimus treatment in liver transplantation according to clinical practice: A Spanish multicentre cohort ﻿

Everolimus Treatment in Liver Transplantation. A Spanish Multicentre Cohort. ﻿

Indicaciones actuales de tratamiento triple para la hepatitis C ﻿

Infarto hepatico masivo tras ablacion por radiofrecuencia ﻿

Intrahepatic Cholangiocarcinoma (I-CC) or Mixed Hepatocellular-Cholangiocarcinoma (HCC-CC) in Patients Undergoing Liver Transplantation (LT) ﻿

Intrahepatic Cholangiocarcinoma (I-CC) or Mixed Hepatocellular-Cholangiocarcinoma (HCC-CC) in Patients Undergoing Liver Transplantation (LT). A Spanish Case Control Multicenter Study ﻿

Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation: a Spanish matched cohort multicenter study ﻿

Late recurrence of hepatocellular carcinoma after liver transplantation: Is an active surveillance for recurrence needed? ﻿

Profiles and clinical management of hepatitis C patients in Spain: DisHCovery study ﻿

A comparison of dobutamine and levosimendan on hepatic blood flow in patients with a low cardiac output state after cardiac surgery: a randomised controlled study

Baseline creatinine and hemodynamic response predicts reversal hepatorenal syndrome type 1 with terlipressin and albumin therapy

Basiliximab en el tratamiento del rechazo celular agudo resistente a los corticoides postrasplante hepático

Calcineurin inhibitors in liver transplantation: to be or not to be.

Cholangitis and multiple liver abscesses after percutaneous ethanol injection (PEI) for recurrent hepatocellular carcinoma (HCC)

Colangitis esclerosante

Comienzo de hepatitis aguda grave autoinmune refractaria a tratamiento convencional, rescatada con infliximab

Decisiones terapéuticas en el tratamiento del carcinoma hepatocelular y patrones de uso de sorafenib. Resultados del estudio internacional observacional GIDEON en España

Differences in the incidence and clinical evolution of early neurotoxicity after liver transplantation based on tacrolimus formulation used in the immunosuppressive induction protocol

Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation

Estrategias para evitar la hepatitis B de novo postrasplante hepático (II)

Everolimus treatment in liver transplantation according to clinical practice: A Spanish multicentre cohort

Everolimus Treatment in Liver Transplantation. A Spanish Multicentre Cohort.

Indicaciones actuales de tratamiento triple para la hepatitis C

Infarto hepatico masivo tras ablacion por radiofrecuencia

Intrahepatic Cholangiocarcinoma (I-CC) or Mixed Hepatocellular-Cholangiocarcinoma (HCC-CC) in Patients Undergoing Liver Transplantation (LT)

Intrahepatic Cholangiocarcinoma (I-CC) or Mixed Hepatocellular-Cholangiocarcinoma (HCC-CC) in Patients Undergoing Liver Transplantation (LT). A Spanish Case Control Multicenter Study

Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation: a Spanish matched cohort multicenter study

Late recurrence of hepatocellular carcinoma after liver transplantation: Is an active surveillance for recurrence needed?

Profiles and clinical management of hepatitis C patients in Spain: DisHCovery study